InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,718.57
(
0.28%
)
US TECH 100
19,306.80
(
0.05%
)
Dow Jones
42,124.65
(
0.15%
)
Brent Oil
73.59
(
-0.41%
)
Bitcoin
63,361.47
(
-0.41%
)
Post# of 253196
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Whalatane

Send PM Follow Ignore
Followers 125
Posts 21117
Boards Moderated 0
Alias Born 06/13/2011

Whalatane

Member Level

Re: poorgradstudent post# 209399

Friday, 02/24/2017 8:29:31 PM

Friday, February 24, 2017 8:29:31 PM

Post# of 253196
AKAO well if U have time I'd appreciate your opinion of the CARE trial

http://investors.achaogen.com/releasedetail.cfm?ReleaseID=1003671

Colistin , from what I know , is the current last line of defense when patients don't respond to standard antibiotics such as penicillin . Not only does this drug have toxic side effects to kidneys and the nervous system , its becoming less effective ...

Plazomicin ( AKAO ) appears to be more effective with fewer side effects

Kiwi
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up